Latest Articles
Letter to the Editor Open Access

Off Label Use of Suboxone for Treatment Resistant Depression
George Kamajian, Robert Cable, Jonathan Greco, Brady Laughlin and Tanya deGroot
Published on: May 4, 2016
doi: 10.17756/jrdsas.2016-021
Citation: Kamajian G, Cable R, Greco J, Laughlin B, deGroot T. 2016. Off Label Use of Suboxone for Treatment Resistant Depression. J Reward Defic Syndr Addict Sci 2(1): 1-2.
PDF (Download Full text)
Open Access

Acknowledgement of Manuscript Reviewers JRDS Volume-1 (2015)

Published on: January 8, 2016
doi: 10.17756/jrds.2015-020
Citation: Acknowledgement of Manuscript Reviewers Volume-1 (2015). J Reward Defic Syndr 1(4): 124.
PDF (Download Full text)
Research Article Open Access

Drug Addiction and Manifestations of Indirect Self- Destructiveness
Konstantinos Tsirigotis, Wojciech GruszczyƄski and Marta Tsirigotis-Maniecka
Published on: December 23, 2015
doi: 10.17756/jrds.2015-019
Citation: Tsirigotis K, GruszczyƄski W, Tsirigotis-Maniecka M. 2015. Drug Addiction and Manifestations of Indirect Self-Destructiveness. J Reward Defic Syndr 1(4): 119-123.
HTML (View Full text) | PDF (Download Full text)
Conference Proceeding Open Access

Proceedings of the First Reward Deficiency Syndrome Summit (RDS-2015)

Published on: November 30, 2015
doi: 10.17756/jrds.2015-suppl1
Citation: Proceedings of the First Inaugural Reward Deficiency Syndrome (RDS-Summit). J Reward Defic Syndr 1(Suppl 1): S1-S15.
PDF (Download Full text)
Meeting Report Open Access

Report on the Inaugural Reward Deficiency Syndrome Summit (RDS-1)
Kenneth Blum and Rajendra D. Badgaiyan
Published on: November 28, 2015
doi: 10.17756/jrds.2015-018
Citation: Blum K and Badgaiyan RD. 2015. Report on the Inaugural Reward Deficiency Syndrome Summit (RDS-1). J Reward Defic Syndr 1(4): 117-118.
HTML (View Full text) | PDF (Download Full text)
Short Commentary Open Access

Brain Reward Pathway Dysfunction in Maternal Depression and Addiction: A Present and Future Transgenerational Risk
Benjamin C. Nephew, Christopher Murgatroyd, Florent Pittet and Marcelo Febo
Published on: October 30, 2015
doi: 10.17756/jrds.2015-017
Citation: Nephew BC, Murgatroyd C, Pittet F, Febo M. 2015. Brain Reward Pathway Dysfunction in Maternal Depression and Addiction: A Present and Future Transgenerational Risk. J Reward Defic Syndr 1(3): 105-116.
HTML (View Full text) | PDF (Download Full text)
Hypothesis Open Access

Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction
Kenneth Blum, Peter K. Thanos, Marlene Oscar-Berman, Marcelo Febo, David Baron, Rajendra D. Badgaiyan, Eliot Gardner, Zsolt Demetrovics, Claudia Fahlke, Brett C. Haberstick, Kristina Dushaj and Mark S. Gold
Published on: October 23, 2015
doi: 10.17756/jrds.2015-016
Citation: Blum K, Thanos PK, Oscar-Berman M, Febo M, Baron D, et al. 2015. Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction. J Reward Defic Syndr 1(3): 95-104.
HTML (View Full text) | PDF (Download Full text)
Editorial Open Access

Addiction Treatment in America: After Money or Aftercare?
David Miller, Merlene Miller, Kenneth Blum, Rajendra D. Badgaiyan and Marcelo Febo
Published on: October 21, 2015
doi: 10.17756/jrds.2015-015
Citation: Miller D, Miller M, Blum K, Badgaiyan RD, Febo M. 2015. Addiction Treatment in America: After Money or Aftercare? J Reward Defic Syndr 1(3): 87-94.
HTML (View Full text) | PDF (Download Full text)
Brief Report Open Access

Designer Drugs: A Synthetic Catastrophe
James Fratantonio, Lawrence Andrade and Marcelo Febo
Published on: August 10, 2015
doi: 10.17756/jrds.2015-014
Citation: Fratantonio J, Andrade L, Febo M. 2015. Designer Drugs: A Synthetic Catastrophe. J Reward Defic Syndr 1(2): 82-86.
HTML (View Full text) | PDF (Download Full text)
Correction Open Access

Correction: Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely?
Rajendra D. Badgaiyan, Sampada Sinha and Kenneth Blum
Published on: June 30, 2015
doi: 10.17756/jrds.2015-013
Citation: Badgaiyan RD, Sinha S, Blum K. 2015. Correction: Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely? J Reward Defic Syndr 1(2): 81.
HTML (View Full text) | PDF (Download Full text)